FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804368675> ?p ?o ?g. }

• W2804368675 endingPage "10573" @default.
• W2804368675 startingPage "10561" @default.
• W2804368675 abstract "Host recognition of intracellular viral RNA and subsequent induction of cytokine signaling are tightly regulated at the cellular level and are a target for manipulation by viruses and therapeutics alike. Here, we characterize chromosome 6 ORF 106 (C6orf106) as an evolutionarily conserved inhibitor of the innate antiviral response. C6orf106 suppresses the synthesis of interferon (IFN)-α/β and proinflammatory tumor necrosis factor (TNF) α in response to the dsRNA mimic poly(I:C) and to Sendai virus infection. Unlike canonical inhibitors of antiviral signaling, C6orf106 blocks interferon-regulatory factor 3 (IRF3) and, to a lesser extent, NF-κB activity without modulating their activation, nuclear translocation, cellular expression, or degradation. Instead, C6orf106 interacts with IRF3 and inhibits IRF3 recruitment to type I IFN promoter sequences while also reducing the nuclear levels of the coactivator proteins p300 and CREB-binding protein (CBP). In summary, we have defined C6orf106 as a negative regulator of antiviral immunity that blocks IRF3-dependent cytokine production via a noncanonical and poorly defined mechanism. This work presents intriguing implications for antiviral immunity, autoimmune disorders, and cancer. Host recognition of intracellular viral RNA and subsequent induction of cytokine signaling are tightly regulated at the cellular level and are a target for manipulation by viruses and therapeutics alike. Here, we characterize chromosome 6 ORF 106 (C6orf106) as an evolutionarily conserved inhibitor of the innate antiviral response. C6orf106 suppresses the synthesis of interferon (IFN)-α/β and proinflammatory tumor necrosis factor (TNF) α in response to the dsRNA mimic poly(I:C) and to Sendai virus infection. Unlike canonical inhibitors of antiviral signaling, C6orf106 blocks interferon-regulatory factor 3 (IRF3) and, to a lesser extent, NF-κB activity without modulating their activation, nuclear translocation, cellular expression, or degradation. Instead, C6orf106 interacts with IRF3 and inhibits IRF3 recruitment to type I IFN promoter sequences while also reducing the nuclear levels of the coactivator proteins p300 and CREB-binding protein (CBP). In summary, we have defined C6orf106 as a negative regulator of antiviral immunity that blocks IRF3-dependent cytokine production via a noncanonical and poorly defined mechanism. This work presents intriguing implications for antiviral immunity, autoimmune disorders, and cancer." @default.
• W2804368675 created "2018-06-01" @default.
• W2804368675 creator A5034844046 @default.
• W2804368675 creator A5066212712 @default.
• W2804368675 creator A5074756255 @default.
• W2804368675 creator A5075274490 @default.
• W2804368675 creator A5089130901 @default.
• W2804368675 date "2018-07-01" @default.
• W2804368675 modified "2023-09-30" @default.
• W2804368675 title "C6orf106 is a novel inhibitor of the interferon-regulatory factor 3–dependent innate antiviral response" @default.
• W2804368675 cites W1778677407 @default.
• W2804368675 cites W1987047581 @default.
• W2804368675 cites W1987334631 @default.
• W2804368675 cites W1991478184 @default.
• W2804368675 cites W1994647589 @default.
• W2804368675 cites W1994990671 @default.
• W2804368675 cites W2000563367 @default.
• W2804368675 cites W2003956342 @default.
• W2804368675 cites W2004218622 @default.
• W2804368675 cites W2008458519 @default.
• W2804368675 cites W2015937741 @default.
• W2804368675 cites W2017161741 @default.
• W2804368675 cites W2018571726 @default.
• W2804368675 cites W2020411912 @default.
• W2804368675 cites W2025984031 @default.
• W2804368675 cites W2035509260 @default.
• W2804368675 cites W2035524082 @default.
• W2804368675 cites W2042263540 @default.
• W2804368675 cites W2054109770 @default.
• W2804368675 cites W2061710365 @default.
• W2804368675 cites W2076361525 @default.
• W2804368675 cites W2077291760 @default.
• W2804368675 cites W2092333125 @default.
• W2804368675 cites W2107513655 @default.
• W2804368675 cites W2108404291 @default.
• W2804368675 cites W2118481418 @default.
• W2804368675 cites W2122643628 @default.
• W2804368675 cites W2127898507 @default.
• W2804368675 cites W2137128945 @default.
• W2804368675 cites W2141137217 @default.
• W2804368675 cites W2148138332 @default.
• W2804368675 cites W2153833981 @default.
• W2804368675 cites W2161208630 @default.
• W2804368675 cites W2162420861 @default.
• W2804368675 cites W2165873626 @default.
• W2804368675 cites W2170550202 @default.
• W2804368675 cites W2255798748 @default.
• W2804368675 cites W2273966940 @default.
• W2804368675 cites W2304255558 @default.
• W2804368675 cites W2304684998 @default.
• W2804368675 cites W2470298068 @default.
• W2804368675 cites W2496331681 @default.
• W2804368675 cites W263253127 @default.
• W2804368675 cites W2772315545 @default.
• W2804368675 cites W2781893963 @default.
• W2804368675 doi "https://doi.org/10.1074/jbc.ra117.001491" @default.
• W2804368675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6036214" @default.
• W2804368675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29802199" @default.
• W2804368675 hasPublicationYear "2018" @default.
• W2804368675 type Work @default.
• W2804368675 sameAs 2804368675 @default.
• W2804368675 citedByCount "14" @default.
• W2804368675 countsByYear W28043686752020 @default.
• W2804368675 countsByYear W28043686752021 @default.
• W2804368675 countsByYear W28043686752022 @default.
• W2804368675 countsByYear W28043686752023 @default.
• W2804368675 crossrefType "journal-article" @default.
• W2804368675 hasAuthorship W2804368675A5034844046 @default.
• W2804368675 hasAuthorship W2804368675A5066212712 @default.
• W2804368675 hasAuthorship W2804368675A5074756255 @default.
• W2804368675 hasAuthorship W2804368675A5075274490 @default.
• W2804368675 hasAuthorship W2804368675A5089130901 @default.
• W2804368675 hasBestOaLocation W28043686751 @default.
• W2804368675 hasConcept C111289621 @default.
• W2804368675 hasConcept C136449434 @default.
• W2804368675 hasConcept C159047783 @default.
• W2804368675 hasConcept C164027704 @default.
• W2804368675 hasConcept C17991360 @default.
• W2804368675 hasConcept C203014093 @default.
• W2804368675 hasConcept C2522874641 @default.
• W2804368675 hasConcept C2776178377 @default.
• W2804368675 hasConcept C2776914184 @default.
• W2804368675 hasConcept C2780127873 @default.
• W2804368675 hasConcept C2780209191 @default.
• W2804368675 hasConcept C51785407 @default.
• W2804368675 hasConcept C62478195 @default.
• W2804368675 hasConcept C86803240 @default.
• W2804368675 hasConcept C8891405 @default.
• W2804368675 hasConcept C9173399 @default.
• W2804368675 hasConcept C95444343 @default.
• W2804368675 hasConceptScore W2804368675C111289621 @default.
• W2804368675 hasConceptScore W2804368675C136449434 @default.
• W2804368675 hasConceptScore W2804368675C159047783 @default.
• W2804368675 hasConceptScore W2804368675C164027704 @default.
• W2804368675 hasConceptScore W2804368675C17991360 @default.
• W2804368675 hasConceptScore W2804368675C203014093 @default.
• W2804368675 hasConceptScore W2804368675C2522874641 @default.
• W2804368675 hasConceptScore W2804368675C2776178377 @default.

• next